|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Tamibarotene>> Market Analysis Reports |
Market Analysis Reports of Tamibarotene |
|
Tamibarotene (JAN) (CAS 94497-51-5) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Tamibarotene Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Global Market Report of Tamibarotene (CAS 94497-51-5) December 2024 CytRx Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... multiforme; and a registration study of tamibarotene for the treatment of acute ... both B-CLL and GBM. Tamibarotene: Tamibarotene is an orally available, synthetic retinoid ... American development and commercialization of tamibarotene. The license is applies to ... Global Market Report of Keto Tamibarotene (CAS 162661-91-8) December 2024 Syros Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... -dependent kinase 7 (CDK7) inhibitor). SY-1425 (tamibarotene) is an oral, potent and selective agonist ... Global Retinoic Acid Receptor Alpha Market Status, Trends and COVID-19 Impact Report 2022 ... Alitretinoin IRX-5183 SBD-073 Tamibarotene Application Segment Myelodysplastic Syndrome Acute ... Global Retinoic Acid Receptor Beta Market Status, Trends and COVID-19 Impact Report 2022 ... Type Segment Alitretinoin SBD-073 Tamibarotene Tazarotene Application Segment Metabolic Disorders ... Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Retinoic Acid Receptor ... Global Retinoic Acid Receptor Alpha Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 ... Alitretinoin IRX-5183 SBD-073 Tamibarotene Others Market segment by Application can ... Global Retinoic Acid Receptor Beta Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 ... by Type, covers Alitretinoin SBD-073 Tamibarotene Tazarotene Others Market segment by Application ... Global Retinoic Acid Receptor Alpha Market Growth 2025-2031 ... : Alitretinoin IRX-5183 SBD-073 Tamibarotene Others Segmentation by Application: Myelodysplastic Syndrome ... Global Retinoic Acid Receptor Beta Market Growth 2025-2031 ... . Segmentation by Type: Alitretinoin SBD-073 Tamibarotene Tazarotene Others Segmentation by Application: Metabolic ... Retinoic Acid Receptor Alpha Market - Global Outlook and Forecast 2022-2028 ... (%) Alitretinoin IRX-5183 SBD-073 Tamibarotene Others Global Retinoic Acid Receptor ... Retinoic Acid Receptor Beta Market - Global Outlook and Forecast 2022-2028 ... , by Type, 2021 (%) Alitretinoin SBD-073 Tamibarotene Tazarotene Others Global Retinoic Acid ... Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Review, H2 2018 Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Review, H2 2018 SUMMARY Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) ... Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) - Pipeline Review, H2 2018 Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) - Pipeline Review, H2 2018 SUMMARY Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear ... Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Review, H1 2019 Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Review, H1 2019 SUMMARY Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) ... Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) - Pipeline Review, H1 2019 Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) - Pipeline Review, H1 2019 SUMMARY Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear ... Retinoic Acid Receptor Alpha - Pipeline Review, H2 2019 Retinoic Acid Receptor Alpha - Pipeline Review, H2 2019 SUMMARY Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Retinoic acid receptor alpha (RARA) is a nuclear receptor that is encoded by the ... |